国际医药卫生导报2019，Vol.25Issue(22)：3783-3785,3.DOI:10.3760/cma.j.issn.1007-1245.2019.22.042
肺癌放化疗后并发治疗相关性急性髓系细胞白血病1例报告并文献复习
A report and literature review on acute myelocytic leukemia caused by chemoradiotherapy in lung cancer
摘要
Abstract
Objective To explore the relationship between treatment of lung cancer and secondary leukemia and the prevention strategy.Method A case of secondary acute leukemia after chemotherapy for lung cancer was reported and reviewed.Results The case was acute myeloid leukemia (AML),with a history of chemotherapy for lung cancer.The chemotherapy program contained navelbine and cisplatin,and the incubation period was 6 years.The patient is still in treatment and has poor therapeutic effect on AML.Conclusion The risk of leukaemia can be increased in patients with lung cancer by the chemotherapy of navelbine and cisplatin and radiotherapy.The clinical characteristics of secondary AML were similar to that of primary AML,and the prognosis was poor.关键词
肺癌/急性髓系白血病/继发性/抗肿瘤联合化疗方案Key words
Lung cancer/Acute myeloid leukemia/Secondary/Antineoplastic combined chemotherapy引用本文复制引用
李芳,(蕳)雯瑜..肺癌放化疗后并发治疗相关性急性髓系细胞白血病1例报告并文献复习[J].国际医药卫生导报,2019,25(22):3783-3785,3.
